Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2024-04, Vol.390 (16), p.1534-1535
Hauptverfasser:	Wang, Yeming, Hu, Honglin, Cao, Bin
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use COVID-19 - therapy COVID-19 - virology COVID-19 Drug Treatment Humans SARS-CoV-2 Viral Load
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1535
container_issue	16
container_start_page	1534
container_title	The New England journal of medicine
container_volume	390
creator	Wang, Yeming Hu, Honglin Cao, Bin
description
doi_str_mv	10.1056/NEJMc2402378
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3046516042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3046516042</sourcerecordid><originalsourceid>FETCH-LOGICAL-p126t-2cdd14119d8d6d12c640fa1efd2f4a821105f67f72b8d1d0b380da2ed2aaec6f3</originalsourceid><addsrcrecordid>eNo1j0tPAjEYRRsTI4juXJsu3RT7ms6wJARRAmJ8rCdlvjbWdOjYdjD8e0nEu7mbk5MchG4YHTNaqPvn-XLdcEm5KKszNGSFEERKqgboMqUvehyTkws0EJUqSl4UQ7TcRO3xm2t3IUfj9y5iGyKeQu8zftHZmV1O-MflT7x2HkgOZB3ARJ0NnoW9A8ImY_xqOn-4QudW-2SuTz9CHw_z99kjWW0WT7PpinSMq0x4A8AkYxOoQAHjjZLUamYscCt1xdmxxKrSlnxbAQO6FRUFzQ1wrU2jrBihuz9vF8N3b1KuW5ca473emdCnWlCpCqao5Ef09oT229ZA3UXX6nio__vFL-0dWeU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3046516042</pqid></control><display><type>article</type><title>Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply</title><source>MEDLINE</source><source>1990</source><source>EZB Electronic Journals Library</source><creator>Wang, Yeming ; Hu, Honglin ; Cao, Bin</creator><creatorcontrib>Wang, Yeming ; Hu, Honglin ; Cao, Bin</creatorcontrib><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2402378</identifier><identifier>PMID: 38657255</identifier><language>eng</language><publisher>United States</publisher><subject>Administration, Oral ; Adult ; Antiviral Agents - administration & dosage ; Antiviral Agents - therapeutic use ; COVID-19 - therapy ; COVID-19 - virology ; COVID-19 Drug Treatment ; Humans ; SARS-CoV-2 ; Viral Load</subject><ispartof>The New England journal of medicine, 2024-04, Vol.390 (16), p.1534-1535</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38657255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yeming</creatorcontrib><creatorcontrib>Hu, Honglin</creatorcontrib><creatorcontrib>Cao, Bin</creatorcontrib><title>Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><subject>Administration, Oral</subject><subject>Adult</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral Agents - therapeutic use</subject><subject>COVID-19 - therapy</subject><subject>COVID-19 - virology</subject><subject>COVID-19 Drug Treatment</subject><subject>Humans</subject><subject>SARS-CoV-2</subject><subject>Viral Load</subject><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tPAjEYRRsTI4juXJsu3RT7ms6wJARRAmJ8rCdlvjbWdOjYdjD8e0nEu7mbk5MchG4YHTNaqPvn-XLdcEm5KKszNGSFEERKqgboMqUvehyTkws0EJUqSl4UQ7TcRO3xm2t3IUfj9y5iGyKeQu8zftHZmV1O-MflT7x2HkgOZB3ARJ0NnoW9A8ImY_xqOn-4QudW-2SuTz9CHw_z99kjWW0WT7PpinSMq0x4A8AkYxOoQAHjjZLUamYscCt1xdmxxKrSlnxbAQO6FRUFzQ1wrU2jrBihuz9vF8N3b1KuW5ca473emdCnWlCpCqao5Ef09oT229ZA3UXX6nio__vFL-0dWeU</recordid><startdate>20240425</startdate><enddate>20240425</enddate><creator>Wang, Yeming</creator><creator>Hu, Honglin</creator><creator>Cao, Bin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20240425</creationdate><title>Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply</title><author>Wang, Yeming ; Hu, Honglin ; Cao, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p126t-2cdd14119d8d6d12c640fa1efd2f4a821105f67f72b8d1d0b380da2ed2aaec6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Oral</topic><topic>Adult</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral Agents - therapeutic use</topic><topic>COVID-19 - therapy</topic><topic>COVID-19 - virology</topic><topic>COVID-19 Drug Treatment</topic><topic>Humans</topic><topic>SARS-CoV-2</topic><topic>Viral Load</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yeming</creatorcontrib><creatorcontrib>Hu, Honglin</creatorcontrib><creatorcontrib>Cao, Bin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yeming</au><au>Hu, Honglin</au><au>Cao, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2024-04-25</date><risdate>2024</risdate><volume>390</volume><issue>16</issue><spage>1534</spage><epage>1535</epage><pages>1534-1535</pages><eissn>1533-4406</eissn><cop>United States</cop><pmid>38657255</pmid><doi>10.1056/NEJMc2402378</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	EISSN: 1533-4406
ispartof	The New England journal of medicine, 2024-04, Vol.390 (16), p.1534-1535
issn	1533-4406
language	eng
recordid	cdi_proquest_miscellaneous_3046516042
source	MEDLINE; 1990; EZB Electronic Journals Library
subjects	Administration, Oral Adult Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use COVID-19 - therapy COVID-19 - virology COVID-19 Drug Treatment Humans SARS-CoV-2 Viral Load
title	Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T19%3A21%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Simnotrelvir%20for%20Adult%20Patients%20with%20Mild-to-Moderate%20Covid-19.%20Reply&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Wang,%20Yeming&rft.date=2024-04-25&rft.volume=390&rft.issue=16&rft.spage=1534&rft.epage=1535&rft.pages=1534-1535&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2402378&rft_dat=%3Cproquest_pubme%3E3046516042%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3046516042&rft_id=info:pmid/38657255&rfr_iscdi=true